Aminophenols

Medchemexpress LLC Rgx-104 hydrochloride | 610318-03-1 | 99.9% | 632.54 | 1 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

RGX-104 hydrochloride is a small-molecule LXR agonist that modulates innate immunity via transcriptional activation of the ApoE gene. It significantly suppresses the growth of multiple cancer types in animals, including lung cancer, melanoma, glioblastoma, ovarian, renal cell, triple-negative breast, and colon cancer, with some instances showing partial or complete tumor regression.

• Small-molecule LXR agonist.
• Modulates innate immunity via transcriptional activation of the ApoE gene.
• Significantly suppresses the growth of multiple cancer types in animals.
• Treatment causes partial or complete tumor regression in some instances.
• Available in solid form and in solution.

Medchemexpress LLC RGX-104 hydrochloride | 610318-03-1 | 99.9% | 632.54 | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

RGX-104 hydrochloride is a small-molecule LXR agonist that modulates innate immunity through the transcriptional activation of the ApoE gene. It is intended for research use only.

• Modulates innate immunity via transcriptional activation of the ApoE gene.
• Potential anti-cancer activity through suppression of various cancer types, including lung cancer, melanoma, glioblastoma, ovarian, renal cell, triple-negative breast, and colon cancer.
• Induces tumor regression in some cases.
• Available in various quantities.

Medchemexpress LLC RGX-104 (hydrochloride) | 610318-03-1 | 99.9% | 632.54 | 10 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

RGX-104 hydrochloride is a small-molecule LXR agonist that modulates innate immunity via transcriptional activation of the ApoE gene. It is for research use only and not sold to patients.

• LXR agonist
• Modulates innate immunity via transcriptional activation of the ApoE gene
• Oral administration significantly suppresses the growth of multiple cancer types (e.g., lung cancer, melanoma, glioblastoma, ovarian, renal cell, triple-negative breast, and colon cancer) in animals with palpable tumors.
• Can cause partial or complete tumor regression in some instances.

Medchemexpress LLC RGX-104 hydrochloride | 610318-03-1 | 99.9% | 632.54 | 25 MG

Small and Specialty Supplier Partner
Small and/or specialty supplier based on Federal laws and SBA requirements.
Learn More

RGX-104 hydrochloride is a small-molecule LXR agonist that modulates innate immunity via transcriptional activation of the ApoE gene. This compound is for research use only and not sold to patients. Studies show it significantly suppresses the growth of multiple cancer types in animals, even in large tumors, with instances of partial or complete tumor regression.

• Acts as a small-molecule LXR agonist
• Modulates innate immunity through ApoE gene activation
• Significantly suppresses various cancer types in animal models
• Effective against large tumors, with potential for regression
• Applicable across a wide spectrum of malignancies

eMolecules​ ChemScene / 1-(5-Ethynyl-2-hydroxyphenyl)ethanone / 100mg / 726025579 / CS-0566511 / 0.000 / 1350803-03-0 / [null] / 160.172 / C10H8O2

ChemScene / 1-(5-Ethynyl-2-hydroxyphenyl)ethanone / 100mg / 726025579 / CS-0566511 / 0.000 / 1350803-03-0 / [null] / 160.172 / C10H8O2